Edwards Lifesciences Corp.

NYS: EW
Pharmaceuticals
Irvine CA
Title 1Chairman; Chief Executive Officer
Executive 1Mr. Michael A. Mussallem, Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
2015 Revenue (US$ Millions)$2,494
2014 Revenue (US$ Millions)$2,323
Revenue Growth (%)7.35%
Net Income (US$ Millions)$495
Common Shares Outstanding (Millions)$215
Earnings Per Share (US$)$2.25
Price To Earnings Ratio71.79
Total Equity (US$ Millions)$2,503
Return On Equity (%)22.58%
Long Term Debt (US$ Millions)$600
Debt To Equity Ratio (%)0.24%
Market Capitalization (US$ Millions)$17,012
Total Assets (US$ Millions)$4,059
Current Assets (US$ Millions)$2,048
Inventories (US$ Millions)$340
Current Liabilities (US$ Millions)$476
Cost of Goods Sold (US$ Millions)$617
Asset Turnover0.61
Inventory Turnover1.94